Late Hypothermia for Hypoxic-Ischemic Encephalopathy
Completed · Not applicable
Conditions studied: Infant, Newborn, Hypoxia, Brain, Hypoxia-Ischemia, Brain, Encephalopathy, Hypoxic-Ischemic, Hypoxic-Ischemic Encephalopathy, Ischemic-Hypoxic Encephalopathy
In brief
This study is a randomized, placebo-controlled, clinical trial to evaluate whether induced whole-body hypothermia initiated between 6-24 hours of age and continued for 96 hours in infants ≥ 36 weeks gestational age with hypoxic-ischemic encephalopathy will reduce the incidence of death or disability at 18-22 months of age. The study will enroll 168 infants with signs of hypoxic-ischemic encephalopathy at 16 NICHD Neonatal Research Network sites, and randomly assign them to either receive hypothermia or participate in a non-cooled control group.
Key facts
- Study ID
- NCT00614744
- Run by
- NICHD Neonatal Research Network
- People needed
- 168
- Starts
- 2008-04-01
- Expected to finish
- 2016-06-01
- Last updated by the study team
- 2021-03-09
Who can join
Age: 0 and older, up to 0. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Infants born at 36 0/7ths weeks gestational age or greater (by best obstetrical estimate)
- Postnatal age between 6 and 24 hours following birth
- Infants with a high probability of acute hemodynamic compromise, such as those with:
- An acute perinatal event (abruptio placenta, cord prolapse, severe FHR abnormality)
- An Apgar score ≤ 5 at 10 minutes
- Continued need for ventilation initiated at birth for at least 10 minutes
- Cord pH or first postnatal blood gas pH at ≤ 1 hour of ≤ 7.0
- Base deficit on cord gas or first postnatal blood gas at ≤ 1 hour of ≥ 16 mEq/L
- Infants matching the above criteria who also have an abnormal neurological exam showing the presence of moderate or severe encephalopathy
- Infants whose parents/legal guardians have provided consent for enrollment.
- NOTE: These inclusion criteria are identical to the NICHD Neonatal Research Network's 2005 Hypothermia study (see links below), except for the time of entry (6-24 hours vs. < 6 hours of age).
You may not qualify if…
- Any infant with a core body temperature (axilla, rectal) less than 34.0°C for greater than 1 hour
- Presence of a known anomaly or chromosomal aberration
- Birth weight < 1,800 grams
- Infant in extremis
- Infants whose parents/legal guardians or attending physician refuse consent
Where it is running
- University of Alabama at Birmingham — Birmingham, Alabama, United States
- University of California - Los Angeles — Los Angeles, California, United States
- Stanford University — Palo Alto, California, United States
- Yale University — New Haven, Connecticut, United States
- Emory University — Atlanta, Georgia, United States
- Indiana University — Indianapolis, Indiana, United States
- University of Iowa — Iowa City, Iowa, United States
- Tufts Medical Center — Boston, Massachusetts, United States
- Wayne State University — Detroit, Michigan, United States
- Children's Mercy Hospital — Kansas City, Missouri, United States
- University of New Mexico — Albuquerque, New Mexico, United States
- University of Rochester — Rochester, New York, United States
- RTI International — Durham, North Carolina, United States
- Duke University — Durham, North Carolina, United States
- Cincinnati Children's Medical Center — Cincinnati, Ohio, United States
- Case Western Reserve University, Rainbow Babies and Children's Hospital — Cleveland, Ohio, United States
- Research Institute at Nationwide Children's Hospital — Columbus, Ohio, United States
- Univeristy of Pennsylvania — Philadelphia, Pennsylvania, United States
- Brown University, Women & Infants Hospital of Rhode Island — Providence, Rhode Island, United States
- University of Texas Southwestern Medical Center at Dallas — Dallas, Texas, United States
- University of Texas Health Science Center at Houston — Houston, Texas, United States
- University of Utah — Salt Lake City, Utah, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.